loadpatents
Patent applications and USPTO patent grants for Antibody and Receptor Therapeutics Co., Ltd..The latest application filed is for "myostatin inhibitor comprising extracellular water-soluble domains of dlk1 as active ingredient".
Patent | Date |
---|---|
Myostatin inhibitor comprising extracellular water-soluble domains of DLK1 as active ingredient Grant 9,388,223 - Lee , et al. July 12, 2 | 2016-07-12 |
Myostatin Inhibitor Comprising Extracellular Water-Soluble Domains of DLK1 As Active Ingredient App 20150030595 - Lee; Dong Hee ;   et al. | 2015-01-29 |
Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble Domain App 20140072558 - Park; Young Woo ;   et al. | 2014-03-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.